Maqhuzu, P. N., Kreuter, M., Bahmer, T., Kahn, N., Claussen, M., Holle, R., & Schwarzkopf, L. (2021). Cost drivers in the pharmacological treatment of interstitial lung disease. Respiratory research, 22, . https://doi.org/10.1186/s12931-021-01807-8
Chicago Style (17th ed.) CitationMaqhuzu, Phillen Nozibuyiso, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, and Larissa Schwarzkopf. "Cost Drivers in the Pharmacological Treatment of Interstitial Lung Disease." Respiratory Research 22 (2021). https://doi.org/10.1186/s12931-021-01807-8.
MLA (9th ed.) CitationMaqhuzu, Phillen Nozibuyiso, et al. "Cost Drivers in the Pharmacological Treatment of Interstitial Lung Disease." Respiratory Research, vol. 22, 2021, https://doi.org/10.1186/s12931-021-01807-8.